You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
"Akashvani" (English) is a programme journal of ALL INDIA RADIO, it was formerly known as The Indian Listener. It used to serve the listener as a bradshaw of broadcasting ,and give listener the useful information in an interesting manner about programmes, who writes them, take part in them and produce them along with photographs of performing artists. It also contains the information of major changes in the policy and service of the organisation. The Indian Listener (fortnightly programme journal of AIR in English) published by The Indian State Broadcasting Service, Bombay, started on 22 December, 1935 and was the successor to the Indian Radio Times in English, which was published beginning ...
None
Welcome to the proceedings of ICASEM-2023, hosted by the Raipur Institute of Technology, India. This conference, held on December 23, 2023, brought together global researchers, professionals, and students to share innovative ideas in science, engineering, and management. These proceedings showcase a diverse range of interdisciplinary topics discussed during the conference, reflecting a collective effort to address the challenges of our evolving world. We extend our gratitude to contributors, reviewers, sponsors, and partners for their vital role in making ICASEM-2023 a success. These proceedings aim to contribute significantly to global academic enrichment and foster enduring collaborations in the ever-changing landscape of science, engineering, and management.
Includes abstracts of papers of various symposia
The complexity of cancer demands an integrated approach from both a cancer biology standpoint and a pharmaceutical basis to understand the different anticancer modalities. Current research has been focused on conventional and newer anticancer modalities, recent discoveries in cancer research, and also the advancements in cancer treatment. There is a current need for more research on the advances in cancer therapeutics that bridge the gap between basic research (pharmaceutical drug development processes, regulatory issues, and translational experimentation) and clinical application. Recent promising discoveries such as immunotherapies, promising therapies undergoing clinical trials, synthetic...